Efficacy and Safety of CTL019 in the First US Phase II Multicenter Trial in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of an Interim Analysis
暂无分享,去创建一个
Krysta D Schlis | S. Grupp | B. Levine | C. June | S. Davies | S. Maude | M. Boyer | M. Verneris | P. Wood | M. Pulsipher | C. Capitini | J. Levine | T. Driscoll | R. Mody | K. August | C. Phillips | Lan Yi